C Delacourt, M Le Bourgeois, MP D'Ortho, C Doit, P Scheinmann, J Navarro, A Harf, DJ Hartmann and C Lafuma
Departement de Physiologie, INSERM U 296, Faculte de Medecine, Creteil, France.

A growing body of evidence suggests that neutrophil-derived proteinases play a major role in lung tissue damage in cystic fibrosis (CF). Most previous studies have focused on serine proteinases such as neutrophil elastase, providing no information on the extent to which metalloproteinases participate in proteolytic processes in CF. To address this issue, we evaluated the contribution of one of the major neutrophil metalloproteinases, i.e., 95 kDa gelatinase (type IV collagenase), to the total gelatinolytic activity measured in sputum specimens from 27 patients with CF. Compared with asthmatic children (n = 9), CF patients had a 6.7 times greater level of total gelatinase activity in sputum revealed by zymography. The 95 kDa gelatinase was increased 3.7-fold in the CF subjects (2,441 +/- 411 [SEM] arbitrary units [AU] x 10(6) per ml of sputum versus 665 +/- 201 in asthmatics) and the 88-kDa active form 23.2-fold (2,272 +/- 372 AU x 10(6) per ml of sputum versus 98 +/- 43, respectively). Using radiolabeled 3H- gelatin as the substrate, we demonstrated uninhibited gelatinolytic activity in all CF patients; this activity was significantly correlated to disease severity as assessed by pulmonary function tests. Western blotting using anti-tissue inhibitor of metalloproteinase (anti-TIMP) and anti-95/88-kDa gelatinase antibodies demonstrated a more than 10- fold excess of 95/88 kDa gelatinase over TIMP. Bacterial proteinases from Pseudomonas aeruginosa were shown to contribute little to the gelatinolytic activity measured in sputum supernatants from patients with CF, although culture supernatants from various P. aeruginosa strains expressed gelatinolytic activity in vitro. Finally, lung damage, as assessed by increased type IV collagen degradation products in sputum, was significantly correlated to concentrations of active 88 kDa gelatinase. These data argue for a significant role of 95/88 kDa gelatinase in airway damage in CF.

This article has been cited by other articles:

				A. Gaggar, Y. Li, N. Weathington, M. Winkler, M. Kong, P. Jackson, J. E. Blalock, and J. P. Clancy Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L96 - L104. [Abstract] [Full Text] [PDF]

				P. M. Henson, G. P. Cosgrove, and R. W. Vandivier State of the Art. Apoptosis and Cell Homeostasis in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, August 1, 2006; 3(6): 512 - 516. [Full Text] [PDF]

				K. S. Lee, K. H. Min, S. R. Kim, S. J. Park, H. S. Park, G. Y. Jin, and Y. C. Lee Vascular Endothelial Growth Factor Modulates Matrix Metalloproteinase-9 Expression in Asthma Am. J. Respir. Crit. Care Med., July 15, 2006; 174(2): 161 - 170. [Abstract] [Full Text] [PDF]

				E. Elass, L. Aubry, M. Masson, A. Denys, Y. Guerardel, E. Maes, D. Legrand, J. Mazurier, and L. Kremer Mycobacterial Lipomannan Induces Matrix Metalloproteinase-9 Expression in Human Macrophagic Cells through a Toll-Like Receptor 1 (TLR1)/TLR2- and CD14-Dependent Mechanism Infect. Immun., October 1, 2005; 73(10): 7064 - 7068. [Abstract] [Full Text] [PDF]

				R. H. Hubner, S. Meffert, U. Mundt, H. Bottcher, S. Freitag, N. E. El Mokhtari, T. Pufe, S. Hirt, U. R. Folsch, and B. Bewig Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation Eur. Respir. J., March 1, 2005; 25(3): 494 - 501. [Abstract] [Full Text] [PDF]

				M. Takemura, A. Niimi, M. Minakuchi, H. Matsumoto, T. Ueda, K. Chin, and M. Mishima Bronchial Dilatation in Asthma: Relation to Clinical and Sputum Indices Chest, April 1, 2004; 125(4): 1352 - 1358. [Abstract] [Full Text] [PDF]

				C. M. Hartog, J. A. Wermelt, C. O. Sommerfeld, W. Eichler, K. Dalhoff, and J. Braun Pulmonary Matrix Metalloproteinase Excess in Hospital-acquired Pneumonia Am. J. Respir. Crit. Care Med., February 15, 2003; 167(4): 593 - 598. [Abstract] [Full Text] [PDF]

				F Ratjen, C-M Hartog, K Paul, J Wermelt, and J Braun Matrix metalloproteases in BAL fluid of patients with cystic fibrosis and their modulation by treatment with dornase alpha Thorax, November 1, 2002; 57(11): 930 - 934. [Abstract] [Full Text] [PDF]

				C. Danan, P.-H. Jarreau, M.-L. Franco, G. Dassieu, C. Grillon, I. A. Alsamad, C. Lafuma, A. Harf, and C. Delacourt Gelatinase activities in the airways of premature infants and development of bronchopulmonary dysplasia Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L1086 - L1093. [Abstract] [Full Text] [PDF]

				T. Okamoto, G. Valacchi, K. Gohil, T. Akaike, and A. van der Vliet S-Nitrosothiols Inhibit Cytokine-Mediated Induction of Matrix Metalloproteinase-9 in Airway Epithelial Cells Am. J. Respir. Cell Mol. Biol., October 1, 2002; 27(4): 463 - 473. [Abstract] [Full Text] [PDF]

				Leader of the Working Group: M.M. Kelly, Members of the Working Group:, V. Keatings, R. Leigh, C. Peterson, J. Shute, P. Venge, and R. Djukanovic Analysis of fluid{-}phase mediators Eur. Respir. J., July 1, 2002; 20(37_suppl): 24S - 39s. [Full Text] [PDF]

				K. H. Choi, H. B. Lee, M. Y. Jeong, Y. K. Rhee, M. J. Chung, Y. G. Kwak, and Y. C. Lee The Role of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Cryptogenic Organizing Pneumonia* Chest, May 1, 2002; 121(5): 1478 - 1485. [Abstract] [Full Text] [PDF]

				C. Delacourt, S. Herigault, C. Delclaux, A. Poncin, M. Levame, A. Harf, F. Saudubray, and C. Lafuma Protection Against Acute Lung Injury by Intravenous or Intratracheal Pretreatment with EPI-HNE-4, a New Potent Neutrophil Elastase Inhibitor Am. J. Respir. Cell Mol. Biol., March 1, 2002; 26(3): 290 - 297. [Abstract] [Full Text] [PDF]

				M.-L. Franco, P. Waszak, G. Banalec, M. Levame, C. Lafuma, A. Harf, and C. Delacourt Pre- and Postnatal Lung Development, Maturation, and Plasticity: LPS-induced lung injury in neonatal rats: changes in gelatinase activities and consequences on lung growth Am J Physiol Lung Cell Mol Physiol, March 1, 2002; 282(3): L491 - L500. [Abstract] [Full Text] [PDF]

				C. A. Rivera-Marrero, W. Schuyler, S. Roser, J. D. Ritzenthaler, S. A. Newburn, and J. Roman M. tuberculosis induction of matrix metalloproteinase-9: the role of mannose and receptor-mediated mechanisms Am J Physiol Lung Cell Mol Physiol, March 1, 2002; 282(3): L546 - L555. [Abstract] [Full Text] [PDF]

				S. R. Petermann, C. Doetkott, and L. Rust Elastase Deficiency Phenotype of Pseudomonas aeruginosa Canine Otitis Externa Isolates Clin. Vaccine Immunol., May 1, 2001; 8(3): 632 - 636. [Abstract] [Full Text] [PDF]

				S. LIM, N. ROCHE, B. G. OLIVER, W. MATTOS, P. J. BARNES, and K. FAN CHUNG Balance of Matrix Metalloprotease-9 and Tissue Inhibitor of Metalloprotease-1 from Alveolar Macrophages in Cigarette Smokers . Regulation by Interleukin-10 Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1355 - 1360. [Abstract] [Full Text] [PDF]

				W.-Y. Su, R. H. Jaskot, J. Richards, S. R. Abramson, J. F. Woessner Jr., W.-H. Yu, and K. L. Dreher Induction of pulmonary matrilysin expression by combustion and ambient air particles Am J Physiol Lung Cell Mol Physiol, July 1, 2000; 279(1): L152 - L160. [Abstract] [Full Text] [PDF]

				G. Mautino, C. Henriquet, D. Jaffuel, J. Bousquet, and F. Capony Tissue Inhibitor of Metalloproteinase-1 Levels in Bronchoalveolar Lavage Fluid from Asthmatic Subjects Am. J. Respir. Crit. Care Med., July 1, 1999; 160(1): 324 - 330. [Abstract] [Full Text]

				H. Lemjabbar, P. Gosset, E. Lechapt-Zalcman, M.-L. Franco-Montoya, B. Wallaert, A. Harf, and C. Lafuma Overexpression of Alveolar Macrophage Gelatinase B (MMP-9) in Patients with Idiopathic Pulmonary Fibrosis . Effects of Steroid and Immunosuppressive Treatment Am. J. Respir. Cell Mol. Biol., May 1, 1999; 20(5): 903 - 913. [Abstract] [Full Text]

				H. LEMJABBAR, P. GOSSET, C. LAMBLIN, I. TILLIE, D. HARTMANN, B. WALLAERT, A. B. TONNEL, and C. LAFUMA Contribution of 92 kDa Gelatinase/Type IV Collagenase in Bronchial Inflammation during Status Asthmaticus Am. J. Respir. Crit. Care Med., April 1, 1999; 159(4): 1298 - 1307. [Abstract] [Full Text] [PDF]

				M. BOSSÉ, J. CHAKIR, M. ROUABHIA, L.-P. BOULET, M. AUDETTE, and M. LAVIOLETTE Serum Matrix Metalloproteinase-9:Tissue Inhibitor of Metalloproteinase-1 Ratio Correlates with Steroid Responsiveness in Moderate to Severe Asthma Am. J. Respir. Crit. Care Med., February 1, 1999; 159(2): 596 - 602. [Abstract] [Full Text]

				A. M. VIGNOLA, L. RICCOBONO, A. MIRABELLA, M. PROFITA, P. CHANEZ, V. BELLIA, G. MAUTINO, P. D'ACCARDI, J. BOUSQUET, and G. BONSIGNORE Sputum Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 Ratio Correlates with Airflow Obstruction in Asthma and Chronic Bronchitis Am. J. Respir. Crit. Care Med., December 1, 1998; 158(6): 1945 - 1950. [Abstract] [Full Text] [PDF]

				I. DURIEU, S. PEYROL, D. GINDRE, G. BELLON, D. V. DURAND, and Y. PACHECO Subepithelial Fibrosis and Degradation of the Bronchial Extracellular Matrix in Cystic Fibrosis Am. J. Respir. Crit. Care Med., August 1, 1998; 158(2): 580 - 588. [Abstract] [Full Text] [PDF]

				G. H. Caughey, W. W. Raymond, and K. C. Fang Porcine origin of human sputum trypsin? Am J Physiol Lung Cell Mol Physiol, July 1, 1998; 275(1): L200 - L202. [Abstract] [Full Text] [PDF]

				O Eickelberg, C. Sommerfeld, C Wyser, M Tamm, F Reichenberger, P. Bardin, M Soler, M Roth, and A. Perruchoud MMP and TIMP expression pattern in pleural effusions of different origins Am. J. Respir. Crit. Care Med., December 1, 1997; 156(6): 1987 - 1992. [Abstract] [Full Text]

				G. Mautino, N. Oliver, P. Chanez, J. Bousquet, and F. Capony Increased Release of Matrix Metalloproteinase-9 in Bronchoalveolar Lavage Fluid and by Alveolar Macrophages of Asthmatics Am. J. Respir. Cell Mol. Biol., November 1, 1997; 17(5): 583 - 591. [Abstract] [Full Text]